TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -1 | -3 | -7 | 30 | 0 | 0 | 5 |
| S | %wins | 100 | 50 | 100 | 0 | 63 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/15/20 16:13 | 1/13/20 | OSMT | Osmotica Pharmaceuticals Plc | Health | Drug | Pharmaceutical Preparations | Venkataraman Sriram | NY | DT | P | 6,250 | 5.00 | 0 | 1,250 | 6 | 21,701 | I | ||||||||||||||||
11/26/19 17:36 | 11/25/19 | OPTN | Optinose, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venkataraman Sriram | NY | DT | S | -11,456 | 9.17 | 0 | -1,250 | -61 | 808 | I | |||||||||||||||
6/13/18 16:50 | 6/11/18 | OPTN | Optinose, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venkataraman Sriram | NY | DT | S | -60,131 | 20.92 | 0 | -2,875 | -77 | 879 | I | |||||||||||||||
3/21/17 17:00 | 3/17/17 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Venkataraman Sriram | NY | DT | S | -36,600 | 12.20 | 7 | -3,000 | -47 | 3,442 | I | 528 | 47 | 37 | 37 | -4 | -5 | 0 | 0 | 3 | 0 | |||||
11/23/16 16:33 | 11/21/16 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Venkataraman Sriram | NY | DT | S | -22,500 | 9.00 | 6 | -2,500 | -37 | 4,282 | I | 151 | 316 | 31 | 20 | -2 | -5 | 1 | -1 | -8 | -13 | 30 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |